Oslo, February 28, 2024 -Observe Medical ("the Company" or "Observe Medical")
has received the first order for its UnoMeter products from Siramo GmbH,
following the strategic Letter of Intent (LOI) announced in December 2023.

This order marks the expansion into the German market, a key territory for the
distribution of the UnoMeter product range. The founders of Siramo GmbH are
industry experts with a rich background from the former largest Convatec
distributor in Germany for UnoMeter. Therefore, this initial order and our
formalized agreement represents a significant step towards capitalizing on this
substantial growth opportunity.

Jørgen Mann, Chief Commercial Officer at Observe Medical, stated, "The first
order from Siramo GmbH is a testament to our strategic initiative to broaden our
reach and strengthen our ties with key distribution partners. The German market
is pivotal for the UnoMeter portfolio, and our presence here is integral to
achieving our goal of becoming a global leader in urine measurement solutions".

For further information, please contact:

Rune Nystad, CEO Observe Medical
Mobile: +47 916 24683
E-mail: rune.nystad@observemedical.com

Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04345
E-mail: perarne.nygard@observemedical.com

About Observe Medical